These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 18617335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C, Rehbein S, Hudelet P, Blanchet M, Lapostolle B, Cariou C, Duboeuf M, Goutebroze S.
    Vaccine; 2009 May 11; 27(21):2789-93. PubMed ID: 19366576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E, Belbis G, Hamers C, Moulin V, Lilin T, Moreau F, Millemann Y, Montange C, Sailleau C, Durand B, Desprat A, Viarouge C, Hoffmann B, de Smit H, Goutebroze S, Hudelet P, Zientara S.
    Vaccine; 2011 Mar 16; 29(13):2495-502. PubMed ID: 21256877
    [Abstract] [Full Text] [Related]

  • 7. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
    Barros SC, Cruz B, Luís TM, Ramos F, Fagulha T, Duarte M, Henriques M, Fevereiro M.
    Vet Microbiol; 2009 Jun 12; 137(3-4):252-9. PubMed ID: 19233575
    [Abstract] [Full Text] [Related]

  • 8. Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.
    Savini G, Monaco F, Citarella R, Calzetta G, Panichi G, Ruiu A, Caporale V.
    Vet Ital; 2004 Jun 12; 40(4):664-7. PubMed ID: 20422608
    [Abstract] [Full Text] [Related]

  • 9. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J, Hägglund S, Bréard E, Riou M, Zohari S, Comtet L, Olofson AS, Gélineau R, Martin G, Elvander M, Blomqvist G, Zientara S, Valarcher JF.
    Vaccine; 2014 Nov 20; 32(49):6614-21. PubMed ID: 25312275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
    Breard E, Belbis G, Viarouge C, Nomikou K, Haegeman A, De Clercq K, Hudelet P, Hamers C, Moreau F, Lilin T, Durand B, Mertens P, Vitour D, Sailleau C, Zientara S.
    Vaccine; 2015 Jan 15; 33(4):512-8. PubMed ID: 25500308
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2.
    Di Emidio B, Nicolussi P, Patta C, Ronchi GF, Monaco F, Savini G, Ciarelli A, Caporale V.
    Vet Ital; 2004 Jan 15; 40(4):640-4. PubMed ID: 20422602
    [Abstract] [Full Text] [Related]

  • 13. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    van der Sluijs MT, Schroer-Joosten DP, Fid-Fourkour A, Vrijenhoek MP, Debyser I, Gregg DA, Dufe DM, Moulin V, Moormann RJ, de Smit AJ.
    Vaccine; 2012 Jan 11; 30(3):647-55. PubMed ID: 22107846
    [Abstract] [Full Text] [Related]

  • 14. Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.
    Monaco F, De Luca N, Spina P, Morelli D, Liberatore I, Citarella R, Conte A, Savini G.
    Vet Ital; 2004 Jan 11; 40(4):657-60. PubMed ID: 20422606
    [Abstract] [Full Text] [Related]

  • 15. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ, Heasman L, Batten CA, Oura CA, Plana-Durán J, Yuen HM, Wylie AD.
    Vet J; 2011 May 11; 188(2):193-6. PubMed ID: 20466568
    [Abstract] [Full Text] [Related]

  • 16. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
    Moulin V, Noordegraaf CV, Makoschey B, van der Sluijs M, Veronesi E, Darpel K, Mertens PP, de Smit H.
    Vaccine; 2012 Mar 09; 30(12):2228-35. PubMed ID: 22207091
    [Abstract] [Full Text] [Related]

  • 17. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA, Wood JL, Sanders AJ, Bin-Tarif A, Henstock M, Edwards L, Floyd T, Simmons H, Batten CA.
    Vaccine; 2009 Dec 09; 27(52):7326-30. PubMed ID: 19786141
    [Abstract] [Full Text] [Related]

  • 18. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
    Oura CA, Wood JL, Floyd T, Sanders AJ, Bin-Tarif A, Henstock M, Edwards L, Simmons H, Batten CA.
    Vaccine; 2010 Mar 24; 28(15):2749-53. PubMed ID: 20123052
    [Abstract] [Full Text] [Related]

  • 19. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K, Bulatov Y, Taranov D, Yershebulov Z, Koshemetov Z, Zhunushov A, Renukaradhya GJ, Tabynov K, Abduraimov Y.
    Vet Microbiol; 2018 Nov 24; 226():23-30. PubMed ID: 30389040
    [Abstract] [Full Text] [Related]

  • 20. Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.
    Savini G, Monaco F, Conte A, Migliaccio P, Casaccia C, Salucci S, Di Ventura M.
    Vet Ital; 2004 Nov 24; 40(4):631-4. PubMed ID: 20422600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.